Protein modification by SUMO affects a wide range of protein substrates. Surprisingly, although SUMO pathway mutants display strong phenotypes, the function of individual SUMO modifications is often enigmatic, and SUMOylation-defective mutants commonly lack notable phenotypes. Here, we use DNA double-strand break repair as an example and show that DNA damage triggers a SUMOylation wave, leading to simultaneous multisite modifications of several repair proteins of the same pathway. Catalyzed by a DNA-bound SUMO ligase and triggered by single-stranded DNA, SUMOylation stabilizes physical interactions between the proteins. Notably, only wholesale elimination of SUMOylation of several repair proteins significantly affects the homologous recombination pathway by considerably slowing down DNA repair. Thus, SUMO acts synergistically on several proteins, and individual modifications only add up to efficient repair. We propose that SUMOylation may thus often target a protein group rather than individual proteins, whereas localized modification enzymes and highly specific triggers ensure specificity.
INTRODUCTION
Posttranslational modifications (PTMs) greatly expand the range of functions of proteins. The majority of such modifications are attached functional groups (like phosphate, acetate, or lipids), which change the activities or localization of proteins or induce structural alterations. Moreover, because PTMs are usually reversible and thus have switch-like properties, they are instrumental for the regulation and directionality of cellular pathways and signaling cascades. PTMs typically target individual proteins, and thus, PTM enzymes usually act highly selectively.
A special PTM class is protein modification by covalent attachment of proteins of the ubiquitin family. For ubiquitylation, the principles of substrate selectivity and the mechanistic consequences of the modification are well understood (Kerscher et al., 2006) . High specificity toward individual substrates is achieved by a great diversity of ubiquitin ligases and numerous deconjugation enzymes. In the case of ubiquitin's proteolytic role, the ubiquitin modification (usually in the form of a lysine (K)-48 or K6 and K29 polyubiquitin chain) is recognized by dedicated ubiquitin receptors, which escort the polyubiquitylated protein to the proteasome (Finley, 2009; Richly et al., 2005) . In cases when ubiquitin does not function as a proteolytic tag (e.g., monoubiquitin; K63-linked polyubiquitin chain), the modified proteins are recognized by different kinds of ubiquitin receptors (e.g., receptors engaged in protein sorting) or binding partners that possess ubiquitin-binding domains. Notably, numerous ubiquitin-binding domains exist, some of which exhibit specificity for certain types of polyubiquitin linkages or even the length of the polyubiquitin chain.
Much less is known regarding how modification by the ubiquitin-related protein SUMO affects the function of substrates and how specificity is provided. Surprisingly, even though SUMOylation targets a large number of cellular proteins as well, its enzymatic machinery, both for conjugation and deconjugation, is much more simply organized compared to the elaborate ubiquitin pathway (Geiss-Friedlander and Melchior, 2007) . In fact, only a handful of enzymes have been identified that mediate SUMOylation and de-SUMOylation, and their specificity in vitro seems rather promiscuous. Likewise, the recognition of the SUMO modification is surprisingly simple, as only two SUMO-binding motifs, a short hydrophobic sequence known as SUMO-interacting motif (SIM) and a specific zinc finger (ZZ zinc finger), have been identified (Danielsen et al., 2012; Song et al., 2004) . Some additional selectivity may come from substrate or SIM modification by other PTMs (Stehmeier and Muller, 2009; Ullmann et al., 2012) , but overall, the question of specificity in the SUMO pathway remains largely unexplained.
SUMO is essential for viability for most eukaryotes, and consequently, mutants defective in components of the SUMO pathway are either lethal or have strong pleiotropic phenotypes (Geiss-Friedlander and Melchior, 2007) . Judging from these phenotypes, SUMO plays numerous cellular roles, ranging from signal transduction to DNA transactions, e.g., DNA repair. Indeed, the majority of known SUMO substrates are nuclear proteins, but the significance of the SUMO modification is known for a few substrates only. SUMOylation of the DNA excision repair enzyme thymine-DNA glycosylase (TDG) is a rare example of a conformational change induced by the SUMO modification (Steinacher and Schä r, 2005) . This enzymatically important structural alteration is achieved through an intramolecular interaction of conjugated SUMO with a SIM of TDG. Another well-understood example is SUMOylation of proliferating cell nuclear antigen (PCNA) (Hoege et al., 2002; Papouli et al., 2005; Pfander et al., 2005) . In this case, SUMOylation recruits Srs2, a recombination-inhibiting enzyme, which removes the recombinase Rad51 from chromatin. For PCNA interaction, Srs2 possesses a PIP (PCNA-interacting protein) box, but crucial additional affinity for SUMOylated PCNA is provided by a SIM, located near the PIP box in Srs2's carboxyl (C)-terminal tail (Armstrong et al., 2012; Pfander et al., 2005) . However, PCNA SUMOylation might be a special case as the same residue in PCNA (K164) is also alternatively targeted by mono-and K63-linked polyubiquitylation for other repair functions (Hoege et al., 2002) . Another singular case is SUMOylation of RanGAP of higher eukaryotes as this protein is not only a substrate but is also part of multisubunit SUMO ligase (Werner et al., 2012) .
For the vast majority of currently identified SUMO substrates, the biological significance and the mechanistic consequences of SUMOylation are not known. Surprisingly, in the few cases in which the SUMOylation acceptor lysine residues had been identified, the respective mutants (lysine to arginine replacements; KR) often barely exhibit deleterious phenotypes (Sacher et al., 2006; Silver et al., 2011) . In fact, this paradoxical discrepancy between strong phenotypes of SUMO pathway mutants and the scarceness of phenotypes of mutants deficient in specific SUMO modifications seems characteristic for the SUMO pathway. Because of this feature, one could even argue that several in vivo SUMOylation events are ''silent'' modifications caused by a promiscuous specificity of a simple organized enzymatic pathway.
Here, rather than by analyzing phenotypes of SUMO pathway mutants, we address SUMOylation specificity and function at the substrate level. We focused on DNA double-strand break (DSB) repair by homologous recombination (HR) as this pathway is well characterized and shows strong ties to the SUMO system (Altmannova et al., 2010; Branzei et al., 2006; Cremona et al., 2012; Dou et al., 2011; Galanty et al., 2009; Maeda et al., 2004; Morris et al., 2009; Ohuchi et al., 2008; Sacher et al., 2006; Torres-Rosell et al., 2007) . SUMO pathway mutants exhibit robust sensitivities toward reagents that generate DSBs in vivo, and several HR proteins are known to be SUMOylated. Nonetheless, in the rare cases in which the SUMO acceptor sites have been studied, the corresponding mutants exhibit only very mild phenotypes and mainly only when the demand for HR is very high (Ohuchi et al., 2008; Sacher et al., 2006) . Prompted by this finding and because the greater part of HR proteins is SUMO modified, we speculated that perhaps the SUMOylated proteins act in concert. Indeed, we found that SUMOylation targets a protein group rather than a specific protein and found that individual modifications act synergistically. We finally discuss a model in which regulated and highly spatially restricted SUMOylation provides glue-like properties to nearby substrates in order to foster their physical interactions and to stabilize cellular protein complexes.
RESULTS
A Synchronous DNA Damage-Triggered SUMOylation Wave Targets a Whole Set of HR Proteins To address the enigma of specificity in the SUMO pathway, we selected SUMOylation of HR proteins as a model for our study. DSB repair is initiated by the heterotrimeric MRX complex (Mre11, Rad50, and Xrs2), which recognizes and stabilizes the broken chromosome ends (Lisby et al., 2004) . These ends are prepared for DSB repair via HR by nuclease-mediated singlestranded DNA (ssDNA) formation (resection), followed by its rapid coating with the heterotrimeric RPA complex (Rfa1, Rfa2, and Rfa3). Subsequently, RPA is removed from ssDNA and replaced by the recombinase Rad51 with the help of Rad52 and Rad59. The formed Rad51 nucleoprotein filament is then engaged in homology search, followed by strand annealing and final repair (Lisby et al., 2004) .
Previous work has shown that the greater part of HR proteins is modified by SUMO (Cremona et al., 2012; Dou et al., 2010; Sacher et al., 2006) . We first aimed to complement these findings by screening for SUMO conjugates that accumulated upon DNA damage. We treated cells with the DNA-alkylating agent methyl methanesulfonate (MMS), which primarily causes replication stalling and DSBs, and compared the level of SUMO-conjugates from MMS-treated and untreated cells by using a SILAC-based mass spectrometry protocol (Mann, 2006) (Figure 1A , left). This screen identified 844 different potential SUMO conjugates; the abundance of most of them did not change upon DNA damage. Strikingly, among those that were strongly enriched in the sample derived from MMS-treated cells were specifically HR proteins (Figure 1A , right). When we studied these proteins individually, we noticed that, in practically all cases, SUMOylation yielded multiple species, suggesting that the proteins are perhaps SUMO modified at multiple sites (Figures S1A-S1C available online). Neither the mass spectrometric approach nor a direct analysis identified SUMOylation of Rad51, indicating that the filament-forming recombinase is not a SUMO target. Notably, SUMOylation of the HR proteins occurred predominantly after exposure to MMS (Figures S1A-S1C). MMS-induced SUMOylation was also found for the checkpoint proteins Rad9 and Mrc1 and checkpoint kinases Mec1 and Tel1 (yeast homologs of mammalian ATR and ATM) ( Figures S1D-S1G ). However, their SUMOylation was already considerable in the absence of MMS, suggesting that perhaps endogenous DNA damage (e.g., caused by replication errors) is already sufficient to trigger their SUMOylation.
The observed activity of the SUMO system to target a whole set of HR factors seems surprising given that PTMs typically target individual proteins to alter their functions. We thus wondered whether this behavior might be special for HR factors or perhaps typical for many SUMOylation events. Evidence for the latter assumption comes from findings that numerous proteins of the ribosome (Finkbeiner et al., 2011a (Finkbeiner et al., , 2011b Panse et al., 2006) , several septins (Johnson and Blobel, 1999; Johnson and Gupta, 2001; Takahashi et al., 2001) , and many proteins involved in nucleotide excision repair (NER) (Silver et al., 2011) are SUMO modified. Indeed, when we repeated the SILAC approach mentioned above, but this time after exposure to UV light, which creates bulky DNA lesions, we found that proteins specifically involved in NER become increasingly SUMO modified ( Figure 1B ). This suggests that proteins acting within the same pathway are indeed often collectively SUMO modified upon a specific stimulus.
Because the HR proteins act together functionally and physically, we speculated that the modifications may serve a common purpose and are perhaps synchronously triggered. In fact, we found that the MMS dose dependency of SUMOylation induction was very similar for all HR proteins analyzed and coincided with the activation of checkpoint signaling ( Figure S2A ). Likewise, the kinetics of SUMOylation after MMS treatment was nearly identical for the proteins, suggesting a synchronous burst of SUMOylation, which happens seemingly in parallel to the checkpoint activation wave ( Figure S2B ). Notably, in mutant strains deficient in single HR proteins (Drad51 or Drad52), SUMOylation of other HR proteins still occurred ( Figure S2C ). This suggests that the DNA damage-induced synchronous SUMOylation wave targets Figure S2D ). However, exposure to UV light and 4-nitroquinoline 1-oxide (4NQO), which both cause direct DNA damage, and treatment with the replication inhibitor hydroxyurea (HU) induced SUMOylation only moderately ( Figure S2D ). This suggests that, in particular, reagents that primarily cause DSBs are potent triggers.
We previously noticed that efficient DNA damage-induced SUMOylation of Rad52 requires the MRX complex (Sacher et al., 2006) . Indeed, individual deletions of all three genes encoding MRX subunits strongly reduced SUMOylation of other HR proteins as well ( Figure 2A ). However, because SUMOylation still weakly occurred, MRX potentiates the induction but does not seem to be the primary trigger. MRX acts early in the pathway and is connected to the formation of ssDNA at the DSB by resection (Mimitou and Symington, 2011) . This reaction is usually initiated by the formation of short 3 0 ssDNA overhangs created by the Mre11 subunit of MRX in collaboration with the nuclease Sae2. After this resection-stimulating (but not essential) first step, long tracts of ssDNA are formed by the nuclease Exo1 and also by a parallel pathway involving the Sgs1 helicase acting along with the nuclease Dna2 (Mimitou and Symington, 2008; Zhu et al., 2008) . Interestingly, in the absence of Sae2 (and also in cells additionally defective in the nuclease activity of the MRX subunit Mre11 [mre11-H125N Dsae2]), HR protein SUMOylation was barely affected (Figures 2B and 2C) . In contrast, in cells deficient in the Exo1 protein ( Figure 2B ; Dexo1) or its nuclease activity ( Figure 2D ; exo1-ND) and also in cells lacking Sgs1 ( Figure 2B ), HR protein SUMOylation was strongly reduced. Indeed, only in the absence of both long-range resection pathways (Dexo1 and Dsgs1), SUMOylation of the HR proteins was virtually absent ( Figure 2B ). Exo1 deficiency or absence of its activity also strongly diminished the SUMOylation wave in G1 cells (Figures 2E, 2F, and S2F) , emphasizing the importance of long-range resection for the trigger.
To exclude the possibility that perhaps the process of resection or the formation of DSBs, rather than extended ssDNA, is the primary SUMOylation trigger, we induced ssDNA accumulation by other means that do not rely on DSB formation. First, we exposed G1-arrested cells to UV light ( Figure 2F ), which creates extended ssDNA gaps in DNA via Exo1 activity (Giannattasio et al., 2010) . Second, we used mutants deficient in the nonessential DNA polymerase subunit Pol32 ( Figure S2E ), which, when grown at low temperatures (14 C), undergo faulty replication, leading to the accumulation of ssDNA gaps behind replication forks (Karras and Jentsch, 2010) . Finally, ssDNA at telomeres can be exposed in mutants defective in the telomeric ssDNA-binding protein Cdc13 (Garvik et al., 1995) (cdc13ts; Figure 2G) . Because we observed HR protein SUMOylation (parallel to checkpoint activation) under all these different conditions ( Figures 2F, 2G , and S2E), we conclude that, indeed, extended ssDNA-not a DSB formation per se-is the crucial signal for the SUMOylation wave.
Crosstalk between DNA Damage Response Pathways
Exo1 is phosphorylated at multiple sites by checkpoint kinases, and this modification appears to inhibit its activity, thereby limiting ssDNA accumulation and DNA damage checkpoint activation (Morin et al., 2008) . When we used a phosphorylation-defective exo1 mutant (exo1-SA), which is expected to be irresponsive to checkpoint kinases, we observed that HR protein SUMOylation upon MMS treatment was substantially increased compared to wild-type (WT) cells ( Figure S2F ). This suggests that inactivation of the checkpoint response may lead to increased SUMOylation of HR proteins (as previously observed for Rad52 [Ohuchi et al., 2009] ) not only due to increased DNA damage but perhaps also because Exo1-dependent DNA resection is not repressed. Indeed, inactivation of the checkpoint pathway by removing the genome integrity checkpoint kinase Mec1 (Dmec1 and Dsml1; the used Dsml1 mutant suppresses the otherwise lethal phenotype of Dmec1) or its adaptor protein Ddc2 (Dddc2 and Dsml1) pronouncedly induced HR protein SUMOylation even in the absence of exogenous DNA damage (MMS; Figure S2G ). Similarly, absence of the checkpoint transducer Rad9 (Drad9) also strongly induced the SUMOylation wave ( Figure S2H ). Lastly, mutants deficient in subunits of the 9-1-1 checkpoint clamp (Drad17 or Dmec3) triggered the response ( Figure S2I ). Notably, absence of checkpoint signaling caused significant HR protein SUMOylation even in the absence of long-range resection (Dexo1 and Dsgs1) ( Figure S2J ), probably because ssDNA accumulates in checkpoint mutants at collapsed replication forks. Furthermore, reagents like HU and 4NQO that barely induce HR protein SUMOylation in WT cells strongly triggered the SUMOylation wave if checkpoint signaling is defective (Figure S2K) . We thus conclude that the SUMOylation wave acts parallel to the checkpoint-signaling cascade; however, checkpoint kinases keep ssDNA formation and hence the SUMOylation trigger in check.
The SUMOylation Wave Is Catalyzed by the DNA-Bound SUMO Ligase Siz2 We next asked how ssDNA might trigger HR protein SUMOylation mechanistically. We first speculated that perhaps the responsible SUMO ligase might bind ssDNA specifically. By analyzing single mutants of the genes of the three known SUMO ligases of mitotic cells (Dsiz1, Dsiz2, and mms21-11 catalytically inactive allele), we observed almost complete absence of DNA damage-induced HR protein SUMOylation in cells deficient in Siz2 ( Figures 3A and S3A ). As HR protein SUMOylation was normal in the other two mutants, we conclude that Siz2, See also Figure S2 .
a SUMO-ligase of the conserved PIAS family, is the key enzyme responsible for HR protein SUMOylation. Siz2 indeed binds DNA in vitro, however, only weakly to ssDNA ( Figure 3B ). Furthermore, Siz2 has no discernable selectivity toward structures resembling resected DNA or replication forks ( Figure S3B ). Siz2 possesses an SP-RING domain required for its ligase activity, a PINIT domain linked to substrate binding, and an N-terminally located SAP domain, which mediates DNA binding in other proteins (Palvimo, 2007; Yunus and Lima, 2009) (Figure S3C, scheme #1 ). This SAP domain is indeed crucial as its deletion ( Figure S3C , scheme #2) or replacement of highly conserved residues of this domain by alanine (Siz2-G64A,K66A,L69A; termed Siz2-SAP*; Figure S3C , scheme #3) abolished DNA binding of the purified recombinant proteins in vitro ( Figure 3C ). When Siz2-SAP* was expressed under control of its endogenous promoter, the HR protein SUMOylation wave was severely reduced, but the enzyme was present only at very low intracellular steady-state levels ( Figure 3D ). Nonetheless, the mutant protein was not enzymatically inactive as expression of this variant via a strong promoter (pCUP1-SIZ2-SAP*) partially restored MMS-induced HR protein SUMOylation ( Figures 3E and S3D) . Notably, replacement of the SAP domain by the sequence-specific DNA-binding domain of the transcription factor Gal4 ( Figure S3C , scheme #4) restored the Siz2 protein level, yet without supporting HR protein SUMOylation ( Figure S3E ). In contrast, replacing the Siz2 SAP domain by the SAP domain of the related enzyme Siz1 ( Figure S3C , scheme #5) not only led to a normal enzyme level in vivo but also supported HR protein SUMOylation ( Figure 3F ). We thus conclude that DNA damage-induced HR protein SUMOylation requires SAP-domain-mediated localization of Siz2 on DNA; however, Siz2 binds DNA broadly and not specifically ssDNA.
Because the PINIT domain of the Siz1 SUMO ligase appears to contribute to substrate recognition (Yunus and Lima, 2009) , we also constructed a chimeric Siz2 variant in which we replaced its PINIT domain by the analogous domain of the related enzyme Siz1 ( Figure S3C , scheme #6). However, this Siz2 variant supported HR protein SUMOylation upon DNA damage ( Figure S3F ), indicating that the two enzymes must differ in other aspects. Indeed, a distinguishing feature of Siz2 is that it interacts specifically with the Mre11 subunit of the MRX complex in two-hybrid assays ( Figure 3G ). Mre11 binding is mediated through the C-terminal domain of Siz2, which harbors two SUMO-binding motifs ( Figures 3G and S3C) . Deletion of the C-terminal SIM of Siz2 (SIM 2 ) or amino acid replacements within this motif (Figure S3C , scheme #7; V720A and V721A) not only abolished interaction with Mre11 ( Figure S3G ) but strongly affected HR protein SUMOylation in vivo ( Figure S3H ). Because Mre11 also binds Ubc9 in two-hybrid assays ( Figure 3G ), it seems plausible that binding of Siz2 to Mre11 is achieved through Ubc9-catalyzed SUMOylation of Mre11. Notably, binding of Siz2 to Mre11 is crucial for the full HR protein SUMOylation wave response, but not for HR protein SUMOylation per se, as a Siz2 variant lacking its C-terminal tail ( Figure S3C , scheme #8; aa 416-726, siz2D Cterm) is still able to SUMOylate HR proteins, albeit weakly (Figure 3H) . Furthermore, in the related enzyme Siz1, replacing Siz1's C-terminal tail with the C-terminal tail of Siz2 ( Figure S3C , scheme #9) does not create an enzyme capable of DNA damage-induced SUMOylation of HR proteins ( Figure S3I ). This indicates that the two enzymes not only differ in their tails but differ in other aspects as well. Together, these data suggest that the SAP domain brings Siz2 onto chromatin generally, where it can act on DNA-bound HR proteins, whereas the SIM-containing tail, uniquely present in Siz2, fixes and restricts the enzyme on chromatin to SUMOylated Mre11 in order to promote the full SUMOylation wave.
Artificial DNA Targeting of HR Proteins Is Sufficient to Trigger Their SUMOylation After we ruled out the possibility that the SUMOylation trigger (ssDNA) operates through recruitment of the SUMO ligase specifically to ssDNA, we considered an alternative model. Because HR proteins are assembled on resected DNA, we hypothesized that just recruitment of the HR proteins to DNA is sufficient for their SUMOylation and that only DNA-bound HR proteins are substrates for DNA-localized Siz2 SUMO ligase. To test this idea, we artificially tethered HR proteins to DNA by fusing them to the DNA-binding domain (aa 1-147, BD) of the transcription factor Gal4. Indeed, a BD-Rad52 fusion became efficiently SUMO modified, however, without causing SUMOylation of the earlier-acting HR protein RPA (Rfa1) ( Figures  4A, S4A , and S4B). Importantly, this SUMOylation reaction was independent of DNA damage and bypassed the requirement of ssDNA for the trigger. In contrast, when we used a BD-Rfa1 fusion, not only did Rfa1 become SUMO modified in the absence of DNA damage, but Rad52 did as well ( Figure 4B) . Notably, SUMOylation of BD-Rad52 occurred on the same lysine residues as for WT Rad52 and required Siz2 harboring its SAP domain ( Figures S4A and S4B) . Together, these findings therefore suggest that, indeed, DNA binding of the HR proteins is crucial for triggering their Siz2-dependent SUMOylation. We hence conclude that ssDNA operates as SUMOylation wave trigger by bringing the substrates in vicinity to the DNA-bound SUMO ligase.
Multisite SUMOylation of HR Proteins Promotes Physical Interactions
In agreement with the above findings, we found that the SUMOylated HR proteins are located on chromatin ( Figure 5A ). Because the HR proteins not only function in the same pathway but also physically interact, we next asked whether the SUMO modifications influence HR protein complex formation. Indeed, immunoprecipitation of Rad59 after DNA damage coisolated proportionally much more of the SUMOylated forms of RPA (Rfa1) and Rad52 compared to the respective unmodified species (Figure 5B) . Similarly, RPA (Rfa1 9Myc ) immunoprecipitation brought down with stronger preference the SUMOylated forms of Rad52 ( Figure S5A ). Notably, this preference was further increased when Rad51, the protein that is exchanged for RPA by Rad52, is lacking ( Figure S5A ). In the absence of checkpoint-mediated repression (Dmec1 and Dsml1), preferential binding of RPA (Rfa2 9Myc ) to SUMOylated Rad52 is already significant without exogenous DNA damage but is strongly further increased by DNA damageinduced SUMOylation ( Figure S5B ). Moreover, also in the absence of the SUMO ligase Siz2, binding of RPA to Rad52 was reduced ( Figure S5B ).
To address the in vivo relevance of these modifications, we first aimed to identify the target residues for SUMOylation. The strategy we used is based on a mass spectrometric analysis of peptide pools obtained after trypsin or thermolysin digestion of purified SUMO conjugates. Because these proteinases cleave SUMO (Smt3) close to its C-terminal tail, we expected to get ''branched'' peptides corresponding to HR-protein-derived fragments that had an additional mass of the SUMO-derived fragment at acceptor lysine (EQIGG in case of trypsin and IGG in case of thermolysin). This approach identified two SUMOylation sites in Rfa1 and identified one each in Rfa2, Rfa3, Rad59, and Rad52 ( Figure 5C ). To confirm these sites, we mutated the corresponding genes in the genome in order to replace the acceptor lysine residues by arginine residues. Indeed, SUMOylation in vivo was either abolished (Rfa2 and Rfa3) or strongly reduced ( Figures 5D-5G ), indicating that our approach identified the major attachment sites. Rfa1 and Rad59 possess additional minor SUMOylation sites because the elimination of additional SUMOylation consensus sites reduced modification of these proteins in vivo even further. Notably, expression of a lysine-less SUMO variant (SUMO-KRall) as the only source of SUMO resulted in the disappearance of the di-and tri-SUMOylated species of Rfa2 and Rfa3 ( Figures 5D  and 5E ). Because this SUMO variant cannot form lysine-linked poly-SUMO chains, Rfa2 and Rfa3 seem to be partially modified by poly-SUMOylation. Thus, DNA damage-induced SUMOylation of HR proteins is excessive in that a whole set of repair proteins undergoes multisite modification by SUMO and also by poly-SUMO chains. Importantly, abolishing SUMOylation at individual target sites did not negatively influence SUMOylation at other sites or other proteins, indicating that SUMOylation occurs independently and in parallel.
Because conjugated SUMO typically interacts with SIMs, we next asked whether the HR proteins possess these motifs. Indeed, bioinformatic searches predicted multiple SIMs in basically all repair factors (Table S1 ). When we probed peptides of a length of 12 aa harboring these motifs flanked by their natural sequences for binding to poly-SUMO chains in vitro, we found that, indeed, a significant number had SUMO-binding properties ( Figure S5C ). This indicates that the HR proteins are not only excessively SUMOylated at multiple sites but are also decorated with amino acid motifs that have SUMO-binding properties.
HR Protein SUMOylation Accelerates DNA Repair
Because mutants defective in SUMOylation of individual HR proteins did not exhibit sensitivities toward DNA-damaging agents (data not shown), we asked whether wholesale elimination of SUMOylation sites of multiple HR factors would affect DSB repair. We constructed a mutant strain (termed KR mutant) in which we changed at their endogenous genomic loci the codons of 11 SUMOylation target lysine residues to arginine codons of the core repair proteins RPA, Rad52, and Rad59 (rfa1-K133R, K170R,K427R rfa2-K199R rfa3-K46R rad52-K10R,K11R,K220R rad59-K207R,K228R,K238R) . The obtained KR strain grew at WT rates ( Figure 6A , left) and showed no sensitivity to DNA-damaging agents in plating assays (data not shown). However, when growth curves were measured, the KR strain exhibited a substantial delay of roughly 4 hr upon chronic exposure to MMS compared to WT cells ( Figure 6A, right) . Moreover, spontaneous and MMS-induced interchromosomal recombination rates were reduced in this mutant ( Figure 6B ). The finding that the KR mutant and the strain deficient in Siz2 (Dsiz2) have largely identical phenotypes and are epistatic ( Figures 6A and 6B) revealed that, in the tested DNA repair pathway, Siz2 acts primarily via SUMOylation of HR proteins.
A crucial step in HR-mediated DSB repair is the loading of Rad51 onto resected DSB ends, which is governed by the formation of the RPA-Rad52-Rad59 complex (Davis and Symington, 2003) . Because Siz2-mediated SUMOylation fosters physical interactions within this complex, we tested whether Siz2 affects the loading of Rad51 to a single DSB created by HO endonuclease at the yeast mating type (MAT) locus ( Figure 6C ). Although much less potent than MMS-induced DNA damage, a single DSB was sufficient to trigger the SUMOylation wave both in cells lacking (donor deficient; Dhml Dhmr) or harboring homologous donor sequences (HMLa) for repair ( Figures S6A and S6B ). When we monitored by chromatin immunoprecipitation (ChIP) the recruitment of repair factors to sites 0.2 kb and 5.7 kb distal to the persistent DSB (donor-deficient strain), we found that RPA (Rfa1 9Myc ) was recruited rapidly and with similar kinetics in WT and Dsiz2 cells ( Figure 6C , right top). In contrast, loading of Rad51 was delayed in the absence of HR protein SUMOylation ( Figure 6C , right bottom). Moreover, when we directly assayed for repair of the HO-induced DSB at the MAT locus (mating type switching), we found that repair was substantially delayed in the KR mutant compared to WT ( Figure 6D ). We thus conclude that the SUMOylation wave accelerates DSB repair by fostering HR protein complex formation, which in turn stimulates the loading of the recombinase Rad51 to the sites of repair.
DISCUSSION
Ever since its discovery 15 years ago, the SUMO modification pathway remained enigmatic because of its unorthodox features. Particularly puzzling-especially by comparison to the ubiquitin system-is the small set of enzymes responsible for the modification of a large number of SUMO substrates. This discrepancy, the lack of distinctive modification signals in substrates equivalent to ligase-binding ''degrons'' in the ubiquitin pathway, plus the apparent promiscuity of the SUMOylation enzymes in vitro, have raised the question of how substrate specificity is provided. Equally peculiar is the phenomenon that SUMOylation affects most frequently only a very small fraction of a given substrate and that cells expressing SUMOylationdeficient mutant substrates often barely exhibit deleterious phenotypes.
Protein Group Modification
By using SUMOylation of HR proteins as a case study, we discovered that the SUMO pathway operates surprisingly different from typical protein modification systems. Whereas most PTMs are highly specific for selected individual proteins in order to endow them with new functions or properties, SUMOylation appears to frequently target a protein group rather than an individual protein. In the case of the HR pathway, multiple repair proteins are synchronously modified by a SUMOylation wave. Strikingly, most HR proteins affected by SUMOylation are modified at multiple sites, and these sites are not conserved in homologs of other species. A similar scenario is found for several other protein groups like proteins involved in nucleotide excision repair ( Figure 1B ; Silver et al., 2011) , yeast septins (Johnson and Blobel, 1999; Johnson and Gupta, 2001; Takahashi et al., 2001) , ribosomal proteins (Finkbeiner et al., 2011a (Finkbeiner et al., , 2011b Panse et al., 2006) , and proteins of snoRNPs (Westman and Lamond, 2011) . In all these cases, the SUMOylation machinery seems to target several proteins of the respective complexes synchronously and often at multiple sites. From these findings, we thus assume that ''protein group modification'' is a typical feature of the SUMO pathway. Notable known exceptions from this rule are SUMOylation of RanGAP (Werner et al., 2012) -as the protein is itself a SUMO ligase-and PCNA. Indeed, PCNA SUMOylation (catalyzed by Siz1) is highly special as SUMOylation targets the same conserved acceptor site in PCNA (K164) as ubiquitylation (to conduct different repair pathways) (Hoege et al., 2002) . Notably, protein group modification in the SUMO pathway also differs substantially from other PTM waves like phosphorylation reactions, as most of the SUMO modifications are functionally additive or redundant and do not proceed by a reaction cascade.
SUMOylation Specificity
Protein group modification requires different rules for substrate specificity. Whereas selective modification of an individual substrate involves a highly specific interaction between a modifying enzyme and its substrate, protein group modification may only require close proximity of a promiscuous enzyme to its multiple substrates, plus suitable modification sites, probably within flexible protein domains. Indeed, SUMOylation sites are frequently not conserved and hence are outside of conserved functional domains. Specificity toward a protein group is provided by two principles: a highly specific trigger and topological specificity. As detailed above, the specific SUMOylation trigger for HR proteins is the formation of ssDNA, which serves as a binding platform for the substrates. As we have shown for Rfa1 and Rad52, artificial DNA targeting is sufficient to trigger their SUMOylation (Figure 4) as Siz2 is already on chromatin due to its SAP domain. Thus, topological specificity is provided by locally concentrated substrates (on ssDNA) and a highly localized SUMO ligase. Whereas protein group modification of septins involves localized Siz1 (Johnson and Gupta, 2001; Reindle et al., 2006) , HR protein modification requires Siz2 of the same protein family. Overall, Siz1 and Siz2 have similar domain organizations and DNA-binding properties; however, they differ in Siz2's ability to selectively bind Mre11 of the MRX complex. Because specificity is provided by these two basic principles, there is no need for a large set of different ligases in the SUMO pathway. Importantly, protein group modification also solves the puzzle of why usually only a very small fraction of a given substrate is SUMO modified. In the case of HR proteins, this small fraction apparently represents the DNA-bound population engaged in repair and that is at reach of the Mre11-associated and DNA-bound SUMO ligase.
SUMO as a Protein Glue
Our systematic analysis of SUMOylation sites of HR proteins revealed that individual SUMO modifications act synergistically, which explains why single acceptor site mutants usually exhibit barely any deleterious phenotype. Because SUMOylation of HR proteins fosters protein-protein interactions, the most logical explanation for the observed functional synergy is that individual SUMO-SIM interactions add up affinities for complex formation. Three important features appear to be crucially relevant for this activity: the proteins in question possess low affinities toward their neighbors on their own, even in the absence of SUMOylation; they are modified at multiple sites; and they are decorated with multiple SIMs. Because SIMs are very short sequence motifs, our finding that basically all HR proteins possess multiple in vitro functional SIMs may not be surprising. However, it suggests that they represent widely scattered latent ''adhesive surfaces'' for potential SUMO interactions. We thus like to propose that SUMO functions comparable to a glue. In this model, upon a specific signal, a DNA-bound, concentrated SUMO ligase catalyzes a local ''SUMO spray'' on nearby proteins, thereby potentiating physical interactions and in that way accelerating overall repair. Because the SUMO ligases are enzymatically largely promiscuous, they predictably also modify sites that do not contribute to complex stabilization. In other words, although SUMO modifications (e.g., in the HR pathway) act synergistically and add up for repair, not all modifications are expected to be equally important. Furthermore, superfluous SUMO modifications, not protected by interaction with a SIMcontaining partner, might be rapidly removed by de-SUMOylation enzymes (Geiss-Friedlander and Melchior, 2007) . Because many biological pathways take place within ''nuclear bodies'' or ''foci,'' it seems attractive to speculate that several of these large protein assemblies are stabilized by the mechanism we describe here. An interesting remaining question is how the SUMO-bridged complexes become disassembled once their activities are no longer needed. Attractive possibilities are that disassembly might be promoted by regulated de-SUMOylation, by proteolytic removal involving SUMO-targeted ubiquitin ligases (STUbLs; Galanty et al., 2012; Prudden et al., 2007; Yin et al., 2012) , or perhaps by the activities of ''segregases'' such as Cdc48/p97 of the ubiquitin pathway (Dantuma and Hoppe, 2012; Jentsch and Rumpf, 2007) .
EXPERIMENTAL PROCEDURES Yeast Strains
Yeast (S. cerevisiae) strains used in this study are listed in Table S2 .
Biochemical and Molecular Biology Techniques
The biochemical and molecular biology techniques used in this study are standard procedures. Detailed descriptions for individual methods are provided in Extended Experimental Procedures.
SILAC Mass Spectrometry
For the detection of SUMO conjugates enriched upon MMS and UV light treatment ( Figures 1A and 1B See also Figure S5 and Table S1 .
were UV irradiated (80 J/m 2 ) instead of MMS treatment. Then, His SUMO conjugates were isolated by using denaturing Ni-NTA pull-down and separated on 4%-12% Bis-Tris gel. The whole lane was excised in ten slices and proteins were digested with trypsin and analyzed by LC-MS/MS.
Detection of SUMOylation Sites
For the detection of SUMOylation sites, proteins were digested with trypsin (Shevchenko et al., 1996) or thermolysin. Extracted peptides were analyzed by Orbitrap mass spectrometry (Olsen et al., 2005) and identified by using MaxQuant software (Cox and Mann, 2008) . The data set was searched for peptides harboring extra masses on lysines (branched peptides) corresponding to proteolytic remnants of the C-terminal tail of SUMO. In the case of trypsin digestion, extra masses corresponding to a SUMO remnant with the sequence EQIGG were expected, and in the case of thermolysin digestion, with the sequence IGG.
Detection of SUMO-Interacting Motifs
For the detection of SIMs, 12-mer peptides corresponding to in-silico-predicted SIMs and flanking sequences were synthesized by a MultiPep instrument (INTAVIS Bioanalytical Instruments AG) on a membrane, incubated with poly-SUMO-3 chains (UCL-310; BostonBiochem), and probed analogous to western blotting with antibodies directed against SUMO-2/3. For details, see Extended Experimental Procedures (Peptide Array Immunoblotting). (C) Rad51 loading at the DSB is affected in the absence of Siz2. A single unrepairable DSB was induced by HO endonuclease at MAT of cells lacking HML and HMR (donor-deficient strain). DSB induction was monitored in WT and Siz2-deficient cells (Dsiz2) by real-time quantitative PCR with primers (P MAT ) spanning the HO cut site. ChIP directed against Rad51 and C-terminally Myc-tagged Rfa1 at 0.2 and 5.7 kb distal from DSB was performed 1, 2, and 3 hr after HO induction to compare loading of RPA and Rad51 in the absence of HR protein SUMOylation. The results are the average of at least three independent studies, and error bars represent SEM.
SUPPLEMENTAL INFORMATION
(D) The speed of DSB repair is slowed down in mutants deficient in SUMOylation of RPA, Rad52, and Rad59 (KR mutant). A single repairable DSB (arrow indicates repair reaction) was transiently induced by HO at MATa in WT cells, cells lacking the MRX subunit Rad50 (Drad50) defective in DSB-resection initiation, or the Rad52 protein (Drad52), and the KR mutant. Repair kinetics was measured by real-time quantitative PCR (with primers P A and P B ), following the appearance of repaired product Y a at MAT, 1, 2, and 3 hr after inactivation of HO (shift from galactose to glucose-containing media). The results are the average of at least three independent studies, and error bars represent SEM. See also Figure S6 .
